Endemic throughout Latin America with a prevalence rate of approximately 1.4%, Chagas
disease (CD) is estimated to kill 14,000 people every year, which is more people in the …

Parasitic diseases such as Kala azar (visceral leishmaniasis), Chagas disease (American
trypanosomiasis) and African sleeping sickness (human African trypanosomiasis) are …

Although Brazil was declared free from Chagas disease transmission by the domestic vector
Triatoma infestans, human acute cases are still being registered based on transmission by …

We developed a novel murine model of long-term infection with Trypanosoma cruzi with the
aim to elucidate the pathogenesis of megacolon and the associated adaptive and …

Aims: This article aimed to provide a critical review of the evolution of Chagas' disease
(ChD) in Brazil, its magnitude, historical development and management, and challenges for …

Abstract Background Triatomines in Latin America are natural Chagas disease (ChD)
vectors. Triatomine domiciliation is one of the main factors increasing the occurrence risk of …

Introduction This work aimed to analyze the triatomine infestation scenario in Jaboticatubas
after 30 years of the uninterrupted actions of the Program of Chagas Disease Control …

RESUMO O estudo da doença de Chagas experimental é um modelo de potencial
importância para o entendimento da patogênese do megaesôfago e do megacólon. Vários …

Mais de 100 anos após a doença de Chagas (DC) ter sido descrita pela primeira vez, em
alguns países, como o Brasil, o benznidazole (BZN) é o único medicamento disponível para …

Aims: This paper aimed to provide a critical review of the evolution of Chagas' disease in
Brazil, its magnitude, historical development and management, and challenges for the …